| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V128452 | AL044 | AL044 is an antibody that targets MS4A family proteins. | |
|
V130133 | BI-1206 | BI-1206 is a recombinant antagonistic human monoclonal antibody targeting FcγRIIB (CD32B). | |
|
V130380 | Blidarvetug | 3056024-36-0 | Blidarvetug is a veterinary monoclonal antibody against MS4A1/CD20, which can be used to study canine CD20-positive B-cell lymphoma. |
|
V130387 | BLX-301 | 2170268-76-3 | BLX-301 is a humanized monoclonal antibody that targets CD20. |
|
V130413 | BMS-986458 | 3005272-36-3 | BMS-986458 is a highly selective, orally effective cereblon-based BCL6 PROTAC degrader and antitumor drug. |
|
V130804 | BVX20 | BVX20 is a human monoclonal antibody that binds to CD20. | |
|
V79330 | Eramkafusp Alfa | Eramkafusp Alfa is a human IgG1 antibody targeting the mouse B lymphocyte CD20 antigen MS4A1. | |
|
V139582 | MEDI-552 | MEDI-552 is a human IgG monoclonal antibody that targets CD20/transmembrane 4 domain subfamily A member 1 (MS4A1). | |
|
V139948 | MIL62 | MIL62 is an anti-CD20 monoclonal antibody. | |
|
V140993 | NAV006 | NAV006 is an anti-CD20 antibody variant of rituximab with a dissociation constant (Kd) of 30.5 nM for CD20. | |
|
V141530 | Nofetumomab | Nofetumomab is an anti-human monoclonal antibody that targets CD20. | |
|
V142523 | PF-5212374 | 1169717-01-4 | PF-5212374 is a humanized antibody expressed in CHO cells that targets CD20/MS4A1. |
|
V143447 | PSB102 | PSB102 is a humanized Fc-enhanced IgG1 monoclonal antibody that targets human B cell-specific cell surface antigens and tumor-associated antigen CD20. | |
|
V145958 | TG20 | TG20 is an anti-CD20 monoclonal antibody that binds to specific discontinuous epitopes on CD20, with a dissociation constant (Kd) of 10–20 nM. | |
|
V146582 | TRS-005 | TRS-005 is an anti-CD20 antibody-drug conjugate (ADC) composed of an anti-CD20 monoclonal antibody conjugated to MMAE via a valine-citrate linker. | |
|
V147296 | Zareprumig | 3062698-53-4 | Zareprumig is a human monoclonal antibody that targets CD20/MS4A1 & CD71/TFRC. |